Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Guéry

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
European Journal of Immunology|May 1, 1990
A spontaneous hybridoma producing autoanti-idiotypic antibodies that recognize a V kappa-associated idiotope in mercury-induced autoimmunityJ C Guéry, P Druet
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1995
Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cellsJ C Guéry, L Adorini
Critical Reviews in Immunology|January 1, 1993
Selective immunosuppression of class II-restricted T cells by MHC class II-binding peptidesJ C Guéry, L Adorini
Immunology Series|January 1, 1993
Suppression of T-cell activation by administration of MHC class II-binding peptidesL Adorini, J C Guéry
The Journal of Experimental Medicine|March 1, 1996
Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvantJ C Guéry, F Ria, L Adorini
Springer Seminars in Immunopathology|January 1, 1992
Approaches toward peptide-based immunotherapy of autoimmune diseasesL Adorini, J C Guéry, S Trembleau
Autoimmunity|January 1, 1996
Manipulation of the Th1/Th2 cell balance: an approach to treat human autoimmune diseases?L Adorini, J C Guéry, S Trembleau
Advances in Pharmacology (San Diego, Calif.)|January 1, 1995
Advances in selective immunosuppressionL Adorini, J C Guéry, S Trembleau
Seminars in Immunology|July 1, 1991
Inhibition of T cell activation by blockade of MHC class II moleculesL Adorini, A Valli, J C Guéry
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1995
Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-toleranceJ C Guéry, A Sette, E Appella, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
European Journal of Immunology|May 1, 1990
A spontaneous hybridoma producing autoanti-idiotypic antibodies that recognize a V kappa-associated idiotope in mercury-induced autoimmunityJ C Guéry, P Druet
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1995
Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cellsJ C Guéry, L Adorini
Critical Reviews in Immunology|January 1, 1993
Selective immunosuppression of class II-restricted T cells by MHC class II-binding peptidesJ C Guéry, L Adorini
Immunology Series|January 1, 1993
Suppression of T-cell activation by administration of MHC class II-binding peptidesL Adorini, J C Guéry
The Journal of Experimental Medicine|March 1, 1996
Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvantJ C Guéry, F Ria, L Adorini
Springer Seminars in Immunopathology|January 1, 1992
Approaches toward peptide-based immunotherapy of autoimmune diseasesL Adorini, J C Guéry, S Trembleau
Autoimmunity|January 1, 1996
Manipulation of the Th1/Th2 cell balance: an approach to treat human autoimmune diseases?L Adorini, J C Guéry, S Trembleau
Advances in Pharmacology (San Diego, Calif.)|January 1, 1995
Advances in selective immunosuppressionL Adorini, J C Guéry, S Trembleau
Seminars in Immunology|July 1, 1991
Inhibition of T cell activation by blockade of MHC class II moleculesL Adorini, A Valli, J C Guéry
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1995
Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-toleranceJ C Guéry, A Sette, E Appella, et al.
Pageof 4